Nature Communications (Jul 2019)

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance

  • Xiaoguang Li,
  • Zhida Liu,
  • Anli Zhang,
  • Chuanhui Han,
  • Aijun Shen,
  • Lingxiang Jiang,
  • David A. Boothman,
  • Jian Qiao,
  • Yang Wang,
  • Xiumei Huang,
  • Yang-Xin Fu

DOI
https://doi.org/10.1038/s41467-019-11238-1
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 13

Abstract

Read online

Improper innate sensing within the tumor microenvironment limits immunotherapy success. Here, the authors show that targeting NQO1 triggers immunogenic innate sensing to reactivate T cells and overcome immune checkpoint blockade resistance.